Stay updated on ODM-208 Safety & PK in Metastatic CRPC Clinical Trial
Sign up to get notified when there's something new on the ODM-208 Safety & PK in Metastatic CRPC Clinical Trial page.

Latest updates to the ODM-208 Safety & PK in Metastatic CRPC Clinical Trial page
- Check4 days agoChange DetectedA site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and provides links to updates and FAQs.SummaryDifference0.5%

- Check11 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check18 days agoChange DetectedThe site footer’s revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.7.0 has been added to the study record history. The previous revision v3.6.6 has been removed from the history, indicating an update to the revision metadata.SummaryDifference0.1%

- Check60 days agoChange DetectedThe history now shows a new platform release entry for Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects an internal update to the site rather than changes to study data or content.SummaryDifference0.1%

- Check74 days agoChange DetectedThe history now shows a new version (26, dated 2026-08-12) with Oversight and Study Status sections, signaling updated governance and current study status. A past version entry (2025-07-22) has been removed from the history.SummaryDifference0.4%

Stay in the know with updates to ODM-208 Safety & PK in Metastatic CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ODM-208 Safety & PK in Metastatic CRPC Clinical Trial page.